Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Bone Marrow Transplant. 2004 May; 33(10):1005-9.
-
Adult
-
Aged
-
Disease-Free Survival
-
Female
-
Fusion Proteins, bcr-abl
-
Graft vs Host Disease
-
Hematopoietic Stem Cell Transplantation
-
Histocompatibility Testing
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
-
Leukemia, Myelomonocytic, Chronic
-
Male
-
Middle Aged
-
Primary Myelofibrosis
-
Time Factors
-
Transplantation Conditioning
-
Transplantation, Homologous
-
Treatment Outcome